Literature DB >> 2104829

A1 adenosine receptor of rat testis membranes. Purification and partial characterization.

H Nakata1.   

Abstract

Purification of an A1 adenosine receptor of rat testes was performed using a newly developed affinity chromatography system (Nakata, H. (1989) Mol. Pharmacol. 35, 780-786). The A1 adenosine receptor was solubilized with digitonin from rat testicular membranes and then purified more than 25,000-fold by sequential use of affinity chromatography on xanthine amine congener-immobilized agarose, hydroxylapatite chromatography, re-affinity chromatography on xanthine amine congener-agarose, and finally gel permeation chromatography on TSK-3000SW. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the final preparation showed a single broad band of Mr 41,000 by autoradiography after radioiodination. This Mr 41,000 peptide was also specifically labeled with an A1 adenosine receptor affinity labeling reagent. A high affinity A1 adenosine receptor antagonist, 8-cyclopentyl-1,3-[3H]dipropylxanthine, bound saturably to the purified receptor with a KD of approximately 1.4 nM. The purified receptor also showed essentially the same specificity for adenosine agonists and antagonists as the unpurified receptor preparations, although the affinities of the purified adenosine receptor for agonists were significantly low compared to those of unpurified receptor preparations indicating that the purified A1 adenosine receptor exists as a low agonist-high antagonist affinity state. Deglycosylation of the purified testis adenosine A1 receptors with endoglycosidase F produced an increase in the mobility of the receptor protein to an apparent Mr 30,000 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, similar to that of deglycosylated A1 adenosine receptors of rat brain membranes. Peptide maps of the purified testis and brain A1 adenosine receptors using trypsin and V8 protease suggest that these receptors show some structural homologies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104829

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Analysis of agonist-antagonist interactions at A1 adenosine receptors.

Authors:  E Leung; K A Jacobson; R D Green
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

2.  Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding.

Authors:  M Freissmuth; E Selzer; W Schütz
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

3.  Apparent heterogeneity of cardiac A1 adenosine receptors as revealed by radioligand binding experiments on N-ethylmaleimide-treated membranes.

Authors:  E Leung; K A Jacobson; R D Green
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

4.  Optimal association-saturation procedure for estimating association and dissociation rate parameters in receptor studies. Application to solubilized A1 adenosine receptors.

Authors:  V Casadó; R Franco; J Mallol; C Lluis; E I Canela
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

5.  A1 adenosine receptors can occur manifesting two kinetic components of 8-cyclopentyl-1,3-[3H]dipropylxanthine ([3H]DPCPX) binding.

Authors:  V Casadó; J Mallol; R Franco; C Lluis; E I Canela
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

6.  The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor.

Authors:  F Libert; S N Schiffmann; A Lefort; M Parmentier; C Gérard; J E Dumont; J J Vanderhaeghen; G Vassart
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

7.  Metabolomics coupled with pathway analysis characterizes metabolic changes in response to BDE-3 induced reproductive toxicity in mice.

Authors:  Ziheng Wei; Jing Xi; Songyan Gao; Xinyue You; Na Li; Yiyi Cao; Liupeng Wang; Yang Luan; Xin Dong
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.